PROGRAMME
(as of February 2019, subject to changes) 

TUESDAY, APRIL 9th, 2019

 08.30 - 10.00  

Session 9: Sponsored talks, part I:  Novel drugs and devices in development in status epilepticus and acute seizures
Chairs: Daniel Lowenstein, Matthias Koepp

08.30 - 09.00

Management of prolonged seizures and myoclonic status in CLN2 disease: has this changed over time
Nicola Specchio (on behalf of Biomarin Pharmaceuticals, Inc.)

09.00 - 09.30

Staccato Alprazolam for acute treatment of seizures
Jouko Isojarvi (on behalf of Engage Therapeutics, Inc.)

09.30 - 10.00

Brain distribution and SV2A receptor occupancy of Brivaracetam and Levetiracetam - comparative PET studies in rodents, primates and healthy human subjects
Felix Rosenow (on behalf of UCB, S.A.)

10.00 - 10.30 

Coffee break

10:30 - 12:00

Session 9: Sponsored talks, part II:  Novel drugs and devices in development in status epilepticus and acute seizures
Chairs: Daniel Lowenstein, Peter Kaplan

10.30 - 11.00

Non-Convulsive status epilepticus: letting go of old traditions
Josef Parvizi (on behalf of Ceribell Inc.)

11.00 - 11.30

Enabling drug delivery technologies to address unmet needs in epilepsy
Adrian Rabinowicz (on behalf of Neurelis, Inc.)

11.30 - 12.00

Vagus nerve stimulation in super refractory status epilepticus
Kristl Vonck (on behalf of LivaNova, Plc.)

12:00 - 13:00

Lunch & Posters

13.00 - 14.00

Session 10: Novel treatment approaches in status epilepticus
Chairs: Brian Litt, Nadir Bharucha

13.00 - 13.30

Lessons from the Sage trial
Andrew Cole

13.30 - 14.00

Polytherapy for status epilepticus: the proof of the pudding
Claude Wasterlain

14.00 - 14.30

Coffee break

14.30 - 16.30

Session 11: Novel drugs in the treatment of status epilepticus
Chairs: Nicola Specchio, Tobias Loddenkemper

14.30 - 15.00

New treatments of mitochondrial disease and their impact on status epilepticus
Shamima Rahman

15:00 - 15.30

Fenfluramine : a possible treatment for acute repetitive seizures?
Lieven Lagae

15.30 - 16.00

The promise of new valproic acid amide derivatives in status epilepticus
Meir Bialer

16.00 - 16.30

Propofol Prodrug for the treatment of acute repetitive seizures
Mike Rogawski

   

 14.30 - 16.30

 


Parallel session: Data blitz - EEG, basic aspects and experimental treatments 

Chairs: Rob Wykes, David Henshall
International Panel: C. Agrawal, Majid Gaffar

16.30 - 17.00

Valedictum
Simon Shorvon, Eugen Trinka, Matthew Walter

 

End of Colloquium and Farewell reception

 

SHARE 

1
0
1
s2smodern

Organisation, registration, abstract submission

PCO Tyrol Congress
Ms. Ina Kaehler
Rennweg 3, 6020 Innsbruck
T: +43-(0)512-57 56 00
F: +43-(0)512-57 56 07
E: status@cmi.at

preview

Exhibition and sponsorship

S12! studio 12 GmbH
Kaiser Josef Straße 9
6020 Innsbruck
T: +43-(0)512-890438
F: +43-(0)512-890438-15
E: office@studio12.co.at

Cookies make it easier for us to provide you with our services. With the usage of our services you permit us to use cookies.
More information Ok